A Business Development View of the Oncology Landscape

With an unprecedented number of new investigational agents and companies in today’s oncology space, it can be challenging to track and understand current oncology agents in clinical development, the clinical trials testing them, and what it means for the future.

In this webinar, biopharma partnering expert and Life Sciences consultant,  Linda Pullan, Ph.D. , explores today’s oncology landscape and offered her perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

During Part I of this three-part webinar, Linda discusses: 

  • How today’s oncology market compares to other therapeutic areas
  • Unmet needs
  • Who the major players are and what they are developing
  • What deals are like and the stage of development they are taking place in
  • What we can expect in the upcoming years
 Linda provides a comprehensive overview of today’s robust oncology landscape and offers her clarity and perspectives on many of its complexities and nuances.

 

watch THE
webinar replay

By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .

ABOUT SHAREVAULT

ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.

GUEST PRESENTER:

Company team

Linda Pullan, PhD

Pullan Consulting

Linda and her team at Pullan Consulting offer biotech and pharmaceutical companies consulting in all aspects of partnering. Linda has a  PhD  in Biochemistry, a BS in Chemistry, and over twenty years of drug industry experience, including work on more than 75 deals.  Learn More

OUR SPONSOR: 

Demo Logo
Demo Logo
Demo Logo